Back to search

Article

Validating therapy decisions by reasons for therapy switch in relapsing-remitting multiple sclerosis

2026-04-07

Abstract excerpt

<title>Abstract</title> <p>Models for individualized treatment recommendations in relapsing–remitting multiple sclerosis often select therapies based on predicted risks of relapse and/or 3-month confirmed disability progression (3m-CDP). Recommendations should be interpretable, align with guidelines, and reflect patient perspectives. We validated recently developed prognostic algorithms in eight subgroups defined...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af102d3f-e876-5526-9cb7-5d6fdebe5654
DOI
10.21203/rs.3.rs-8295331/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Validating therapy decisions by reasons for therapy switch in relapsing-remitting multiple sclerosisDOI 10.21203/rs.3.rs-8295331/v1
MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trialSemantic proximity
Dissecting clinical reasoning failures in frontier artificial intelligence using 10,000 synthetic casesSemantic proximity
Comparative effectiveness of natalizumab and fingolimod and injectable therapies in patients with pediatric multiple sclerosis: A registry-based retrospective cohort studySemantic proximity
Ocrelizumab versus Natalizumab in Relapsing-Remitting Multiple Sclerosis: A Registry-Linked Electronic Health Records StudySemantic proximity
Large Language Model - Enhanced Decision Tree Framework for Identifying Multiple Sclerosis Diagnoses from Clinical DocumentationSemantic proximity
Associations of DMT therapies with COVID-19 severity in multiple sclerosisSemantic proximity
The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-center, longitudinal cohort studySemantic proximity
Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort studySemantic proximity
Patterns and predictors of multiple sclerosis phenotype transitionSemantic proximity
Variation in the Accuracy of Endpoint Selection in Clinical Studies for Rare Diseases in Respect of Increasing Knowledge on Disease-Severity MeasurementSemantic proximity
Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis.Semantic proximity
The role of age in choosing high-efficacy treatment for multiple sclerosis – an Austrian MS Database studySemantic proximity
Select a neighboring publication to make it the new centre.